Multiple sources are pointing to a new report that Merck paid Elsevier, a leading publisher, to produce several volumes of the Australasian Journal of Bone and Joint Medicine, which appeared to be a peer-reviewed journal, but was really little more than marketing material for the pharmaceutical company.
Post Tagged with: "elsevier"
Recent Posts
A Standard That Doesn’t Exist: Parliamentary Secretary for Justice Offers Misleading Defence of Bill C-22’s Lower Threshold for Subscriber Information 
More Surveillance Demands to Come?: Government Admits Bill C-22’s Lawful Access Provisions Could Be Expanded 
Win, Lose or Draw?: The Federal Court of Appeal Overrules a Key Copyright Case on Procedural Grounds 
The Lawful Access Debate Begins: Canadians Should Pay Attention to What the Government Isn’t Saying 
The Global Battle for Data Control: How the 2026 U.S. Report on Trade Barriers Targets Data Sovereignty Worldwide
